| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ryan Arthur F is a Director at Regeneron Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 168 sells.
Estimated insider holdings value: $10.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $705.24 | $70,523.80 | - | - | - | |
| Oct 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $1,048.78 | $104,878.24 | - | -32.9% | -42.7% | |
| Sep 3, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $1,178.69 | $117,868.50 | - | -34.8% | -51.8% | |
| Aug 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 97 | $1,084.76 | $105,221.34 | - | -15.6% | -48.9% | |
| Aug 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 1 | $1,100.03 | $1,100.03 | - | -15.6% | -48.9% | |
| Jul 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $1,059.24 | $105,923.96 | - | -0.5% | -49.4% | |
| Jun 3, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 109 | $994.88 | $108,441.55 | - | +18.1% | -50.7% | |
| May 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $899.61 | $89,960.51 | - | +19.3% | -34.7% | |
| Apr 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 100 | $962.53 | $96,253.25 | - | +9.0% | -36.3% | |
| Mar 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sell | 90 | $982.07 | $88,386.44 | - | -1.3% | -28.9% |